Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
With over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
With deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
Creative Biolabs is one of the world’s leading contract organizations (CRO) that has extensive experience in preclinical drug discovery. Our employees are at the core of our success, with the ambition to improving health and increasing access to quality health solutions worldwide. We believe when curious, courageous and collaborative people like you are brought together, a big difference will be made for the development of innovate medicines.
Get a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
The Anti-TNF-α Protein A Scaffold molecule was selected against human TNF-α. The Anti-TNF-α Protein A Scaffold molecule is an ideal affinity ligand as a capture reagent in ELISA and as detection reagent in dot blot. The Anti-TNF-α Protein A Scaffold molecule is modified with a unique C-terminal cysteine for directed single-point chemical modification, facilitating labeling with fluorescent dyes, biotin or coupling to matrices.
Suitable as capture reagent in ELISA and as detection reagent in dot blot.
Anti-TNF-α Protein A scaffold molecule binds to human cytokine tumor necrosis factor α, TNF-α. Cross reactivity with other species has not been tested.
At +4°C is recommended for lyophilized protein. For reconstituted protein in physiological buffer, short-term storage at +4°C is recommended. For long-term storage, the protein solution should be aliquoted and then stored at -20°C. There is no decrease in
Human TNF-α (Tumour Necrosis Factor-alpha) is a nonglycosylated protein of 17 kD belonging to the TNF superfamily of cytokines. TNF-α is produced by activated macrophages and Tlymphocyte and forms trimers spontaneously. TNF-α shows a wide spectrum of biological activities that are mediated by binding to TNFRI and TNFRII receptors. Besides causing cytolysis and cytostasis of many tumour cell lines in vitro, TNF-α has an important role in host defences against pathogens. However, excess TNF-α seen in sepsis and diseases of autoimmune character, has severe pathological consequences and the neutralisation of TNF-α has been a successful treatment procedure for rheumatoid arthritis.
cytokine activity; identical protein binding; protease binding; protein binding; transcription regulatory region DNA binding; tumor necrosis factor receptor binding